 | • レポートコード：D0804-14820 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、126ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、自己免疫疾患治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己免疫疾患治療の種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド系抗炎症薬、生物製剤）、用途別市場規模（病院、クリニック、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Lupin Limited、Bristol-Myers Squibb、Active Biotech、Biogen Idec、Eli Lilly、Amgen、Pfizer、AstraZeneca plc、GlaxoSmithKline、Bayer、4SC AG、Johnson & Johnson、F. Hoffmann-La Roche Ltd.、AutoImmune Inc ・地域別グローバル市場分析 2015年-2020年 ・自己免疫疾患治療の北米市場（アメリカ、カナダ、メキシコ） ・自己免疫疾患治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己免疫疾患治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己免疫疾患治療の南米市場（ブラジル、アルゼンチン） ・自己免疫疾患治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド系抗炎症薬、生物製剤 ・用途別分析：病院、クリニック、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Autoimmune Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 111090 million by 2025, from USD 101510 million in 2019.
The Autoimmune Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Autoimmune Disease Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Autoimmune Disease Treatment market has been segmented into:
Immunosuppressant’s
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal anti-inflammatory drugs
Biologics
By Application, Autoimmune Disease Treatment has been segmented into:
Hospitals
Clinics
Drug Stores
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Autoimmune Disease Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Autoimmune Disease Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Autoimmune Disease Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Autoimmune Disease Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Autoimmune Disease Treatment Market Share Analysis
Autoimmune Disease Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Autoimmune Disease Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Autoimmune Disease Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Autoimmune Disease Treatment are:
Abbott Laboratories
Lupin Limited
Bristol-Myers Squibb
Active Biotech
Biogen Idec
Eli Lilly
Amgen
Pfizer
AstraZeneca plc
GlaxoSmithKline
Bayer
4SC AG
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
Table of Contents
1 Autoimmune Disease Treatment Market Overview
1.1 Product Overview and Scope of Autoimmune Disease Treatment
1.2 Classification of Autoimmune Disease Treatment by Type
1.2.1 Global Autoimmune Disease Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Autoimmune Disease Treatment Revenue Market Share by Type in 2019
1.2.3 Immunosuppressant’s
1.2.4 Anti-Inflammatory Drugs
1.2.5 Corticosteroids
1.2.6 Nonsteroidal anti-inflammatory drugs
1.2.7 Biologics
1.3 Global Autoimmune Disease Treatment Market by Application
1.3.1 Overview: Global Autoimmune Disease Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drug Stores
1.3.5 Other
1.4 Global Autoimmune Disease Treatment Market by Regions
1.4.1 Global Autoimmune Disease Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Autoimmune Disease Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Autoimmune Disease Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Autoimmune Disease Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autoimmune Disease Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Autoimmune Disease Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autoimmune Disease Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lupin Limited
2.2.1 Lupin Limited Details
2.2.2 Lupin Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lupin Limited SWOT Analysis
2.2.4 Lupin Limited Product and Services
2.2.5 Lupin Limited Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Active Biotech
2.4.1 Active Biotech Details
2.4.2 Active Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Active Biotech SWOT Analysis
2.4.4 Active Biotech Product and Services
2.4.5 Active Biotech Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biogen Idec
2.5.1 Biogen Idec Details
2.5.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biogen Idec SWOT Analysis
2.5.4 Biogen Idec Product and Services
2.5.5 Biogen Idec Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly SWOT Analysis
2.6.4 Eli Lilly Product and Services
2.6.5 Eli Lilly Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 AstraZeneca plc
2.9.1 AstraZeneca plc Details
2.9.2 AstraZeneca plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AstraZeneca plc SWOT Analysis
2.9.4 AstraZeneca plc Product and Services
2.9.5 AstraZeneca plc Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline SWOT Analysis
2.10.4 GlaxoSmithKline Product and Services
2.10.5 GlaxoSmithKline Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer SWOT Analysis
2.11.4 Bayer Product and Services
2.11.5 Bayer Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 4SC AG
2.12.1 4SC AG Details
2.12.2 4SC AG Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 4SC AG SWOT Analysis
2.12.4 4SC AG Product and Services
2.12.5 4SC AG Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Johnson & Johnson
2.13.1 Johnson & Johnson Details
2.13.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Johnson & Johnson SWOT Analysis
2.13.4 Johnson & Johnson Product and Services
2.13.5 Johnson & Johnson Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 F. Hoffmann-La Roche Ltd.
2.14.1 F. Hoffmann-La Roche Ltd. Details
2.14.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.14.4 F. Hoffmann-La Roche Ltd. Product and Services
2.14.5 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 AutoImmune Inc
2.15.1 AutoImmune Inc Details
2.15.2 AutoImmune Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 AutoImmune Inc SWOT Analysis
2.15.4 AutoImmune Inc Product and Services
2.15.5 AutoImmune Inc Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Autoimmune Disease Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Autoimmune Disease Treatment Players Market Share
3.2.2 Top 10 Autoimmune Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Autoimmune Disease Treatment Revenue and Market Share by Regions
4.2 North America Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
5 North America Autoimmune Disease Treatment Revenue by Countries
5.1 North America Autoimmune Disease Treatment Revenue by Countries (2015-2020)
5.2 USA Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
6 Europe Autoimmune Disease Treatment Revenue by Countries
6.1 Europe Autoimmune Disease Treatment Revenue by Countries (2015-2020)
6.2 Germany Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
6.4 France Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Autoimmune Disease Treatment Revenue by Countries
7.1 Asia-Pacific Autoimmune Disease Treatment Revenue by Countries (2015-2020)
7.2 China Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
7.5 India Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
8 South America Autoimmune Disease Treatment Revenue by Countries
8.1 South America Autoimmune Disease Treatment Revenue by Countries (2015-2020)
8.2 Brazil Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Autoimmune Disease Treatment by Countries
9.1 Middle East & Africa Autoimmune Disease Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Autoimmune Disease Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Autoimmune Disease Treatment Market Forecast by Type (2019-2024)
10.3 Immunosuppressant’s Revenue Growth Rate (2015-2025)
10.4 Anti-Inflammatory Drugs Revenue Growth Rate (2015-2025)
10.5 Corticosteroids Revenue Growth Rate (2015-2025)
10.6 Nonsteroidal anti-inflammatory drugs Revenue Growth Rate (2015-2025)
10.7 Biologics Revenue Growth Rate (2015-2025)
11 Global Autoimmune Disease Treatment Market Segment by Application
11.1 Global Autoimmune Disease Treatment Revenue Market Share by Application (2015-2020)
11.2 Autoimmune Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Drug Stores Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Autoimmune Disease Treatment Market Size Forecast (2021-2025)
12.1 Global Autoimmune Disease Treatment Market Size Forecast (2021-2025)
12.2 Global Autoimmune Disease Treatment Market Forecast by Regions (2021-2025)
12.3 North America Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
12.6 South America Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Autoimmune Disease Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Autoimmune Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Autoimmune Disease Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Autoimmune Disease Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Autoimmune Disease Treatment Major Business
Table 7. Abbott Laboratories Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Autoimmune Disease Treatment Product and Solutions
Table 10. Abbott Laboratories Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Lupin Limited Corporate Information, Location and Competitors
Table 12. Lupin Limited Autoimmune Disease Treatment Major Business
Table 13. Lupin Limited Autoimmune Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Lupin Limited SWOT Analysis
Table 15. Lupin Limited Autoimmune Disease Treatment Product and Solutions
Table 16. Lupin Limited Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 18. Bristol-Myers Squibb Autoimmune Disease Treatment Major Business
Table 19. Bristol-Myers Squibb Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Bristol-Myers Squibb SWOT Analysis
Table 21. Bristol-Myers Squibb Autoimmune Disease Treatment Product and Solutions
Table 22. Bristol-Myers Squibb Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Active Biotech Corporate Information, Location and Competitors
Table 24. Active Biotech Autoimmune Disease Treatment Major Business
Table 25. Active Biotech Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Active Biotech SWOT Analysis
Table 27. Active Biotech Autoimmune Disease Treatment Product and Solutions
Table 28. Active Biotech Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Biogen Idec Corporate Information, Location and Competitors
Table 30. Biogen Idec Autoimmune Disease Treatment Major Business
Table 31. Biogen Idec Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Biogen Idec SWOT Analysis
Table 33. Biogen Idec Autoimmune Disease Treatment Product and Solutions
Table 34. Biogen Idec Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eli Lilly Corporate Information, Location and Competitors
Table 36. Eli Lilly Autoimmune Disease Treatment Major Business
Table 37. Eli Lilly Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Eli Lilly SWOT Analysis
Table 39. Eli Lilly Autoimmune Disease Treatment Product and Solutions
Table 40. Eli Lilly Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Amgen Corporate Information, Location and Competitors
Table 42. Amgen Autoimmune Disease Treatment Major Business
Table 43. Amgen Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Amgen SWOT Analysis
Table 45. Amgen Autoimmune Disease Treatment Product and Solutions
Table 46. Amgen Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Pfizer Corporate Information, Location and Competitors
Table 48. Pfizer Autoimmune Disease Treatment Major Business
Table 49. Pfizer Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Pfizer SWOT Analysis
Table 51. Pfizer Autoimmune Disease Treatment Product and Solutions
Table 52. Pfizer Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. AstraZeneca plc Corporate Information, Location and Competitors
Table 54. AstraZeneca plc Autoimmune Disease Treatment Major Business
Table 55. AstraZeneca plc Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 56. AstraZeneca plc SWOT Analysis
Table 57. AstraZeneca plc Autoimmune Disease Treatment Product and Solutions
Table 58. AstraZeneca plc Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. GlaxoSmithKline Corporate Information, Location and Competitors
Table 60. GlaxoSmithKline Autoimmune Disease Treatment Major Business
Table 61. GlaxoSmithKline Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 62. GlaxoSmithKline SWOT Analysis
Table 63. GlaxoSmithKline Autoimmune Disease Treatment Product and Solutions
Table 64. GlaxoSmithKline Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bayer Corporate Information, Location and Competitors
Table 66. Bayer Autoimmune Disease Treatment Major Business
Table 67. Bayer Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Bayer SWOT Analysis
Table 69. Bayer Autoimmune Disease Treatment Product and Solutions
Table 70. Bayer Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. 4SC AG Corporate Information, Location and Competitors
Table 72. 4SC AG Autoimmune Disease Treatment Major Business
Table 73. 4SC AG Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 74. 4SC AG SWOT Analysis
Table 75. 4SC AG Autoimmune Disease Treatment Product and Solutions
Table 76. 4SC AG Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Johnson & Johnson Corporate Information, Location and Competitors
Table 78. Johnson & Johnson Autoimmune Disease Treatment Major Business
Table 79. Johnson & Johnson Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Johnson & Johnson SWOT Analysis
Table 81. Johnson & Johnson Autoimmune Disease Treatment Product and Solutions
Table 82. Johnson & Johnson Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. F. Hoffmann-La Roche Ltd. Corporate Information, Location and Competitors
Table 84. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Major Business
Table 85. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 86. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 87. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Product and Solutions
Table 88. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. AutoImmune Inc Corporate Information, Location and Competitors
Table 90. AutoImmune Inc Autoimmune Disease Treatment Major Business
Table 91. AutoImmune Inc Autoimmune Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 92. AutoImmune Inc SWOT Analysis
Table 93. AutoImmune Inc Autoimmune Disease Treatment Product and Solutions
Table 94. AutoImmune Inc Autoimmune Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Autoimmune Disease Treatment Revenue (Million USD) by Players (2015-2020)
Table 96. Global Autoimmune Disease Treatment Revenue Share by Players (2015-2020)
Table 97. Global Autoimmune Disease Treatment Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Autoimmune Disease Treatment Revenue Market Share by Regions (2015-2020)
Table 99. North America Autoimmune Disease Treatment Revenue by Countries (2015-2020)
Table 100. North America Autoimmune Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 101. Europe Autoimmune Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Autoimmune Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Autoimmune Disease Treatment Revenue by Countries (2015-2020)
Table 104. South America Autoimmune Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Autoimmune Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Autoimmune Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 107. Global Autoimmune Disease Treatment Revenue (Million USD) by Type (2015-2020)
Table 108. Global Autoimmune Disease Treatment Revenue Share by Type (2015-2020)
Table 109. Global Autoimmune Disease Treatment Revenue Forecast by Type (2021-2025)
Table 110. Global Autoimmune Disease Treatment Revenue by Application (2015-2020)
Table 111. Global Autoimmune Disease Treatment Revenue Share by Application (2015-2020)
Table 112. Global Autoimmune Disease Treatment Revenue Forecast by Application (2021-2025)
Table 113. Global Autoimmune Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Autoimmune Disease Treatment Picture
Figure 2. Global Autoimmune Disease Treatment Revenue Market Share by Type in 2019
Figure 3. Immunosuppressant’s Picture
Figure 4. Anti-Inflammatory Drugs Picture
Figure 5. Corticosteroids Picture
Figure 6. Nonsteroidal anti-inflammatory drugs Picture
Figure 7. Biologics Picture
Figure 8. Autoimmune Disease Treatment Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Drug Stores Picture
Figure 12. Other Picture
Figure 13. Global Autoimmune Disease Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Autoimmune Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Autoimmune Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Autoimmune Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Autoimmune Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Autoimmune Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Autoimmune Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Autoimmune Disease Treatment Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Autoimmune Disease Treatment Revenue Market Share in 2019
Figure 22. Global Top 10 Players Autoimmune Disease Treatment Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Autoimmune Disease Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Autoimmune Disease Treatment Revenue Market Share by Regions (2015-2020)
Figure 26. Global Autoimmune Disease Treatment Revenue Market Share by Regions in 2018
Figure 27. North America Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Europe Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 30. South America Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 32. North America Autoimmune Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. North America Autoimmune Disease Treatment Revenue Market Share by Countries in 2019
Figure 34. USA Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Canada Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Europe Autoimmune Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Autoimmune Disease Treatment Revenue Market Share by Countries in 2019
Figure 39. Germany Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 40. UK Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 41. France Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Russia Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Italy Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Autoimmune Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Autoimmune Disease Treatment Revenue Market Share by Countries in 2019
Figure 46. China Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Japan Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Korea Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 49. India Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 51. South America Autoimmune Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. South America Autoimmune Disease Treatment Revenue Market Share by Countries in 2019
Figure 53. Brazil Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Autoimmune Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Autoimmune Disease Treatment Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 58. UAE Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Autoimmune Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Global Autoimmune Disease Treatment Revenue Share by Type (2015-2020)
Figure 62. Global Autoimmune Disease Treatment Revenue Share by Type in 2019
Figure 63. Global Autoimmune Disease Treatment Market Share Forecast by Type (2021-2025)
Figure 64. Global Immunosuppressant’s Revenue Growth Rate (2015-2020)
Figure 65. Global Anti-Inflammatory Drugs Revenue Growth Rate (2015-2020)
Figure 66. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 67. Global Nonsteroidal anti-inflammatory drugs Revenue Growth Rate (2015-2020)
Figure 68. Global Biologics Revenue Growth Rate (2015-2020)
Figure 69. Global Autoimmune Disease Treatment Revenue Share by Application (2015-2020)
Figure 70. Global Autoimmune Disease Treatment Revenue Share by Application in 2019
Figure 71. Global Autoimmune Disease Treatment Market Share Forecast by Application (2021-2025)
Figure 72. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 73. Global Clinics Revenue Growth Rate (2015-2020)
Figure 74. Global Drug Stores Revenue Growth Rate (2015-2020)
Figure 75. Global Other Revenue Growth Rate (2015-2020)
Figure 76. Global Autoimmune Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Autoimmune Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Autoimmune Disease Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
Figure 80. Europe Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
Figure 82. South America Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Autoimmune Disease Treatment Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
自己免疫疾患治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Autoimmune Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 自己免疫疾患診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Disease Diagnosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.8% in the forecast period of 2020 to 2025 and will expected to reach USD 3707.6 million by 2025, from USD 3070.2 million in 2019. The Autoimm…
- フォンウィルブランド病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Von Willebrand Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Von Willebra…
- 認知症・アルツハイマー病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Dementia and Alzheimer’s Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- デント病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Dent Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…